These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12675726)

  • 1. Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures.
    Konkle BA; Bauer KA; Weinstein R; Greist A; Holmes HE; Bonfiglio J
    Transfusion; 2003 Mar; 43(3):390-4. PubMed ID: 12675726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative and peripartum prevention of venous thromboembolism in patients with hereditary antithrombin deficiency using recombinant antithrombin therapy.
    Paidas MJ; Forsyth C; Quéré I; Rodger M; Frieling JT; Tait RC;
    Blood Coagul Fibrinolysis; 2014 Jul; 25(5):444-50. PubMed ID: 24686101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations.
    Tiede A; Tait RC; Shaffer DW; Baudo F; Boneu B; Dempfle CE; Horellou MH; Klamroth R; Lazarchick J; Mumford AD; Schulman S; Shiach C; Bonfiglio LJ; Frieling JT; Conard J; von Depka M
    Thromb Haemost; 2008 Mar; 99(3):616-22. PubMed ID: 18327412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin.
    Fitzgerald RH; Spiro TE; Trowbridge AA; Gardiner GA; Whitsett TL; O'Connell MB; Ohar JA; Young TR;
    J Bone Joint Surg Am; 2001 Jun; 83(6):900-6. PubMed ID: 11407799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital Antithrombin Deficiency in a Pregnant Woman with Right Atrium Thrombosis.
    Sabzi F; Khosravi D; Faraji R
    Ethiop J Health Sci; 2015 Oct; 25(4):385-9. PubMed ID: 26949306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
    Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
    J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Human Antithrombin in Pregnant Patients with Hereditary Antithrombin Deficiency: Integrated Analysis of Clinical Data.
    Paidas MJ; Triche EW; James AH; DeSancho M; Robinson C; Lazarchick J; Ornaghi S; Frieling J
    Am J Perinatol; 2016 Mar; 33(4):343-9. PubMed ID: 26461927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery bypass surgery in patients with inherited antithrombin deficiency.
    Clark P; Walker ID; Neilson RF
    Br J Haematol; 1995 Jun; 90(2):479-82. PubMed ID: 7794778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group.
    Comp PC; Spiro TE; Friedman RJ; Whitsett TL; Johnson GJ; Gardiner GA; Landon GC; Jové M;
    J Bone Joint Surg Am; 2001 Mar; 83(3):336-45. PubMed ID: 11263636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
    Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
    J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enoxaparin and heparin comparison of deep vein thrombosis prophylaxis in total hip replacement patients.
    Senaran H; Acaroğlu E; Ozdemir HM; Atilla B
    Arch Orthop Trauma Surg; 2006 Jan; 126(1):1-5. PubMed ID: 16333632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Deep Vein Thrombosis Prophylaxis and Deep Vein Thrombosis Rates After Total Hip and Knee Arthroplasty.
    Bawa H; Weick JW; Dirschl DR; Luu HH
    J Am Acad Orthop Surg; 2018 Oct; 26(19):698-705. PubMed ID: 30153117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin Alone Is Not Enough to Prevent Deep Venous Thrombosis After Total Joint Arthroplasty.
    Woon CYL; Shah RR; Pardi BM; Schwartz BE; Goldstein JM; Cipparrone NE; Goldstein WM
    Orthopedics; 2019 Jan; 42(1):48-55. PubMed ID: 30602046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options.
    Maclean PS; Tait RC
    Drugs; 2007; 67(10):1429-40. PubMed ID: 17600391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Heparin-Resistant Patients with Benefits? Maximizing Biocompatibility in Cardiopulmonary Bypass: Combining ATryn® Recombinant Antithrombin III and Carmeda® Heparin-Bonded Perfusion Circuits: A Case Series.
    Chryssos A; Stroup SJ; Pifer MM; Tawil M; Conrad CG
    J Extra Corpor Technol; 2015 Mar; 47(1):44-7. PubMed ID: 26390679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.
    Sun G; Wu J; Wang Q; Liang Q; Jia J; Cheng K; Sun G; Wang Z
    J Arthroplasty; 2019 Apr; 34(4):789-800.e6. PubMed ID: 30685261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery.
    Renda G; Di Pillo R; D'Alleva A; Sciartilli A; Zimarino M; De Candia E; Landolfi R; Di Giammarco G; Calafiore A; De Caterina R
    Haematologica; 2007 Mar; 92(3):366-73. PubMed ID: 17339186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis.
    Lu X; Lin J
    BMC Musculoskelet Disord; 2018 Sep; 19(1):322. PubMed ID: 30193575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Repeated thromboembolism during pregnancy with constitutional antithrombin deficiency].
    Schumacker-Blay C; Fischer F; Appert A; Lallia A; Carlon M; Dellamonica J; Jambou D; Marabelle B; Bongain A
    J Gynecol Obstet Biol Reprod (Paris); 2004 Jun; 33(4):330-3. PubMed ID: 15170430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.